AU7855594A - Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them - Google Patents
Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing themInfo
- Publication number
- AU7855594A AU7855594A AU78555/94A AU7855594A AU7855594A AU 7855594 A AU7855594 A AU 7855594A AU 78555/94 A AU78555/94 A AU 78555/94A AU 7855594 A AU7855594 A AU 7855594A AU 7855594 A AU7855594 A AU 7855594A
- Authority
- AU
- Australia
- Prior art keywords
- producing
- controlled release
- active
- active substance
- exhibiting rapid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4336159 | 1993-10-22 | ||
DE4336159A DE4336159A1 (en) | 1993-10-22 | 1993-10-22 | Highly effective forms of preparation of sulfonylureas that release the active ingredient quickly or in a controlled manner and processes for their preparation |
PCT/EP1994/003368 WO1995011006A1 (en) | 1993-10-22 | 1994-10-12 | Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7855594A true AU7855594A (en) | 1995-05-08 |
Family
ID=6500829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU78555/94A Abandoned AU7855594A (en) | 1993-10-22 | 1994-10-12 | Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0724427A1 (en) |
JP (1) | JPH09504015A (en) |
AU (1) | AU7855594A (en) |
CA (1) | CA2173366A1 (en) |
DE (1) | DE4336159A1 (en) |
HU (1) | HUT74684A (en) |
NZ (1) | NZ274501A (en) |
WO (1) | WO1995011006A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4064574B2 (en) * | 1998-07-29 | 2008-03-19 | 株式会社資生堂 | Anti-diabetic topical skin preparation |
AP1243A (en) * | 1999-02-01 | 2004-02-02 | Servier Lab | Core tablet for controlled release of gliclazide after oral administration. |
JP5395327B2 (en) | 2003-09-17 | 2014-01-22 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | Mechanism-based targeted pancreatic beta cell imaging and therapy |
DE102004024440B4 (en) | 2004-05-14 | 2020-06-25 | Evonik Operations Gmbh | Polymer powder with polyamide, use in a shaping process and molded body made from this polymer powder |
DE202005021503U1 (en) | 2005-02-19 | 2008-07-24 | Evonik Degussa Gmbh | Polymer powder with Blockpolyetheramid, use in a molding process and molding, made from this polymer powder |
DE102005033379A1 (en) | 2005-07-16 | 2007-01-18 | Degussa Ag | Use of cyclic oligomers in a molding process and molding made by this process |
DE102006015791A1 (en) | 2006-04-01 | 2007-10-04 | Degussa Gmbh | Polymer powder, process for the preparation and use of such a powder and molded articles thereof |
DE102007019133A1 (en) | 2007-04-20 | 2008-10-23 | Evonik Degussa Gmbh | Composite powder, use in a molding process and molding made from this powder |
DE102008000755B4 (en) | 2008-03-19 | 2019-12-12 | Evonik Degussa Gmbh | Copolyamide powder and its preparation, use of copolyamide powder in a molding process and molding, made from this copolyamide powder |
EP2181705A1 (en) | 2008-10-31 | 2010-05-05 | Disphar International B.V. | Sustained-release formulation of gliclazide |
DE102011078720A1 (en) | 2011-07-06 | 2013-01-10 | Evonik Degussa Gmbh | Powder comprising polymer-coated core particles containing metals, metal oxides, metal or metalloid nitrides |
DE102011078719A1 (en) | 2011-07-06 | 2013-01-10 | Evonik Degussa Gmbh | Powder containing polymer-coated particles |
DE102011078721A1 (en) | 2011-07-06 | 2013-01-10 | Evonik Degussa Gmbh | Powder containing polymer-coated polymeric core particles |
DE102011078722A1 (en) | 2011-07-06 | 2013-01-10 | Evonik Degussa Gmbh | Powder containing polymer-coated inorganic particles |
DE102012205908A1 (en) | 2012-04-11 | 2013-10-17 | Evonik Industries Ag | Polymer powder with adapted melting behavior |
EP3455056B1 (en) | 2016-05-13 | 2021-09-22 | Hewlett-Packard Development Company, L.P. | Material sets |
US10717232B2 (en) | 2016-05-13 | 2020-07-21 | Hewlett-Packard Development Company, L.P. | Material sets |
DE202022000644U1 (en) | 2022-03-15 | 2022-04-21 | Evonik Operations Gmbh | Powder for processing in a layer-by-layer process with visible and near-infrared lasers |
EP4245506A1 (en) | 2022-03-15 | 2023-09-20 | Evonik Operations GmbH | Powder for processing in a layer-by-layer method with lasers in the visible and near infrared range |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
DE3927882A1 (en) * | 1989-08-23 | 1991-02-28 | Bauer Kurt Heinz | HIGHLY EFFECTIVE, QUICK-ABSORBABLE PREPARATION FORMS OF GLIBENCLAMIDE, METHOD FOR THE PRODUCTION AND USE THEREOF |
-
1993
- 1993-10-22 DE DE4336159A patent/DE4336159A1/en not_active Withdrawn
-
1994
- 1994-10-12 NZ NZ274501A patent/NZ274501A/en unknown
- 1994-10-12 CA CA002173366A patent/CA2173366A1/en not_active Abandoned
- 1994-10-12 WO PCT/EP1994/003368 patent/WO1995011006A1/en not_active Application Discontinuation
- 1994-10-12 AU AU78555/94A patent/AU7855594A/en not_active Abandoned
- 1994-10-12 JP JP7511289A patent/JPH09504015A/en active Pending
- 1994-10-12 HU HU9600956A patent/HUT74684A/en unknown
- 1994-10-12 EP EP94929538A patent/EP0724427A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE4336159A1 (en) | 1995-04-27 |
HUT74684A (en) | 1997-01-28 |
EP0724427A1 (en) | 1996-08-07 |
JPH09504015A (en) | 1997-04-22 |
WO1995011006A1 (en) | 1995-04-27 |
NZ274501A (en) | 1997-03-24 |
HU9600956D0 (en) | 1996-06-28 |
CA2173366A1 (en) | 1995-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7855594A (en) | Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them | |
AU1108695A (en) | Aza-4-iminoquinolines, methods of preparing them and their use | |
AU5845394A (en) | Biocompatible, surface modified materials and method of making the same | |
AU5337796A (en) | Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same | |
AU2082492A (en) | Keratoprosthesis and method of producing the same | |
AU5422696A (en) | Nox catalyst and method of using the same | |
AU3570193A (en) | Altered antibodies, products and processes relating thereto | |
HUT72166A (en) | Herbicides containing 4-benzoylisoxazole derivatives and process for producing the active ingredient | |
AU6373094A (en) | Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use | |
AU6391794A (en) | Solid state spectrofluorimeter amd method of using the same | |
AU4939493A (en) | Posts, beams and the like, and method of making same | |
AU5641798A (en) | Artificial antibodies, method of producing the same and use thereof | |
AU5983696A (en) | Fragile x related proteins, compositions and methods of maki ng and using the same | |
AU6372496A (en) | Absorbent material, absorbent body made of the material, and method for the preparation of the material | |
AU7938294A (en) | Method for controlled modification of enzymes, enzymes modified in this way and the use of such enzymes | |
AU5922694A (en) | 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use | |
AU4954193A (en) | Fullerene derivatives, method of synthesizing them and their use | |
AU1314995A (en) | Aminosulphonyl-phenyl-1h-pyrrole derivatives, method of their preparation and their use | |
AU673401B2 (en) | 6,7-dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound | |
AU678566B2 (en) | Antiulcer agent and process for preparing the same | |
AU4442996A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them | |
AU692030B2 (en) | Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients | |
AU7654094A (en) | Microparticles, processes for their preparation and their use for the preparation of medicaments | |
AU7384894A (en) | A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers | |
AU5348694A (en) | Octahydronaphthoquinolizines, and methods of making and using thereof |